Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants
Language English Country Switzerland Media print-electronic
Document type Journal Article, Review
PubMed
39406981
PubMed Central
PMC11550250
DOI
10.1007/s10787-024-01578-w
PII: 10.1007/s10787-024-01578-w
Knihovny.cz E-resources
- Keywords
- COVID-19, COVID-19 variants, SARS-CoV-2, Vitamin D, Vitamin D deficiency,
- MeSH
- COVID-19 * immunology MeSH
- COVID-19 Drug Treatment MeSH
- Humans MeSH
- Vitamin D Deficiency * drug therapy immunology MeSH
- Pandemics MeSH
- Receptors, Calcitriol metabolism MeSH
- SARS-CoV-2 immunology MeSH
- Vitamin D * therapeutic use administration & dosage MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Receptors, Calcitriol MeSH
- Vitamin D * MeSH
As of the 7th of July 2024, 775,754,322 confirmed cases of COVID-19, including 7,053,902 deaths worldwide, had been reported to the WHO (World Health Organization). Nevertheless, untill the 15th of July 2024, a total of 13,578,710,228 vaccine doses had been administered, with almost no country spared from COVID-19 attacks. The pathophysiology of this virus is complicated, and several symptoms require a deep understanding of the actual mechanisms. It is unclear why some patients develop severe symptoms while others do not, although literature suggests a role for vitamin D. Vitamin D plays a crucial role in the infection or in ameliorating the severity of symptoms. The mechanism of action of vitamin D and vitamin D deficiency (VDD) is well understood. VDD is associated with increased hospitalization of severely ill patients and increased levels of COVID-19-caused mortality. Recent studies suggest that vitamin D levels and genetic variations in the vitamin D receptor (VDR) gene significantly impact the severity and outcomes of COVID-19, especially in the infections caused by Delta and Omicron variants. Furthermore, VDD causes immune system dysregulation upon infection with SARS-CoV-2, indicating that vitamin D sufficiency is crucial in fighting against COVID-19 infection. The therapeutic effect of vitamin D raises interest in its potential role as a prophylactic and treatment adjunct. We evaluate the immunomodulatory effects of vitamin D and its ability to enhance the efficacy of new antiviral drugs like molnupiravir and paxlovid against SARS-CoV-2. This review discusses the role of vitamin D sufficiency and VDD in COVID-19 initiation and progression, emphasizing the molecular mechanisms by which vitamin D exerts its actions as a proactive step for the next pandemic. However, there is still no clear evidence of vitamin D's impact on prevention and treatment, leading to contradictory findings. Therefore, large-scale randomized trials are required to reach a definitive conclusion. A bibliometric analysis of publications related to vitamin D, immunity, and COVID-19 revealed a significant increase in research activity in this area, particularly in 2020-2024, underscoring the growing recognition of vitamin D's potential role in the context of the pandemic.
Department of Clinical Pharmacy Faculty of Pharmacy University of Sadat City Sadat City 32897 Egypt
Department of Internal Medicine School of Medicine University of California Irvine Irvine CA USA
Department of PharmD Faculty of Pharmacy Jadara University Irbid 21110 Jordan
Faculty of Science Mansoura University Mansoura Egypt
Pharmacology and Toxicology Department Faculty of Pharmacy Menoufia University Shebin El Koum Egypt
Scientific Office Egyptian Society of Pharmacogenomics and Personalized Medicine Cairo Egypt
See more in PubMed
Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi-Aliabadi M, Jafarzadeh B et al (2021) The association between the level of serum 25 (OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case–control study of hospitalized patients in Tehran. Iran J Med Virol 93(4):2359–2364 PubMed
Abraham J, Dowling K, Florentine S (2021) Can optimum solar radiation exposure or supplemented vitamin d intake reduce the severity of COVID-19 symptoms? Int J Environ Res Public Health 18(2):740 PubMed PMC
Ahmed F (2020) A network-based analysis reveals the mechanism underlying vitamin d in suppressing cytokine storm and virus in SARS-CoV-2 infection. Front Immunol 11:590459 PubMed PMC
Ahmed MAS, Atta MNS, Aboul-Seoud MA-L, Tahoun MM, Allah S (2024) Assessment of vitamin d status among Egyptian covid-19 patients. Egypt J Int Med 36(1):63
Alzaman NS, Dawson-Hughes B, Nelson J, D’Alessio D, Pittas AG (2016) Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Am J Clin Nutr 104(1):205–214 PubMed PMC
Ames BN, Grant WB, Willett WC (2021) Does the high prevalence of vitamin D deficiency in African Americans contribute to health disparities? Nutrients 13(2):499 PubMed PMC
Annweiler C, Cao Z, Sabatier JM (2020) Point of view: Should COVID-19 patients be supplemented with vitamin D? Maturitas 140:24–26 PubMed PMC
Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G et al (2022) High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial. PLoS Med 19(5):e1003999 PubMed PMC
Arboleda JF, Urcuqui-Inchima S (2020) Vitamin D supplementation: a potential approach for coronavirus/COVID-19 therapeutics? Front Immunol 11:1523 PubMed PMC
Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K et al (2020) Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 10.1136/postgradmedj-2020-138712 PubMed PMC
Barassi A, Pezzilli R, Mondoni M, Rinaldo RF, DavÌ M, Cozzolino M et al (2023) Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support. Panminerva Med 65:23–29. 10.23736/S0031-0808.21.04277-4 PubMed
Barker T, Henriksen VT, Rogers VE, Aguirre D, Trawick RH, Lynn Rasmussen G et al (2014) Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis. Redox Biol 2(C):466–74 PubMed PMC
Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G (2021) The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metab Clin Exp 119:154753 PubMed PMC
Benskin LL (2020) A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency. Front Public Health 8:513 PubMed PMC
Berridge MJ (2017) Vitamin D deficiency and diabetes. Biochem J 474(8):1321–1332 PubMed
Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319–329 PubMed PMC
Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A et al (2020) Mechanisms in endocrinology: vitamin D and Covid-19. Eur J Endocrinol 183(5):R133–R147 PubMed PMC
Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH (2021) Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR plus 5(1):e10405 PubMed PMC
Bishop EL, Ismailova A, Dimeloe S, Hewison M, White JH (2021) Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus 5(1):e10405 PubMed PMC
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL et al (2020) Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 8(6):546–550 PubMed PMC
Brenner H, Vitamin D (2021) Supplementation to prevent COVID-19 infections and deaths-accumulating evidence from epidemiological and intervention studies calls for immediate action. Nutrients 13(2):411 PubMed PMC
Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 Suppl):S1-34 PubMed PMC
Calder PC, Carr AC, Gombart AF, Eggersdorfer M (2020) Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 12(4):1181 PubMed PMC
Camargo CA Jr, Martineau AR (2020) Vitamin D to prevent COVID-19: recommendations for the design of clinical trials. FEBS J 287(17):3689–3692 PubMed
Carlberg C, Campbell MJ (2013) Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78(2):127–136 PubMed PMC
Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E et al (2021) Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest 44(4):765–771 PubMed PMC
Castillo ME, Costa LME, Barrios JMV, Díaz JFA, Miranda JL, Bouillon R et al (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751 PubMed PMC
Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S et al (2020) Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr. 10.1016/j.clnu.2020.10.055 PubMed PMC
Chandran M, Chan Maung A, Mithal A, Parameswaran R (2020) Vitamin D in COVID-19: dousing the fire or averting the storm?—A perspective from the Asia-Pacific. Osteoporos Sarcopenia 6(3):97–105 PubMed PMC
Christakos S, Dhawan P, Porta A, Mady LJ, Seth T (2011) Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347(1–2):25–29 PubMed PMC
Crissey SD, Ange KD, Jacobsen KL, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M et al (2003) Serum concentrations of lipids, Vitamin D metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos. J Nutr 133(1):160–166 PubMed
Cuschieri S, Grech S (2020) Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom 5:e6 PubMed PMC
D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R et al (2020) 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 12(5):1359 PubMed PMC
de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, de Socorro Barros Viana G (2021) COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? Rev Neurosci 32(2):235–47 PubMed
de Las HN, Martín Giménez VM, Ferder L, Manucha W, Lahera V (2020) Implications of oxidative stress and potential role of mitochondrial dysfunction in COVID-19: therapeutic effects of vitamin D. Antioxidants 9(9):897 PubMed PMC
De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA (2021) Serum 25 (OH) D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol 155(3):381–388 PubMed PMC
Demir M, Demir F, Aygun H (2021) Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J Med Virol. 10.1002/jmv.26832 PubMed PMC
Dhama K, Patel SK, Natesan S, Vora KS, Iqbal Yatoo M, Tiwari R et al (2020) COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother 16(12):2938–2943 PubMed PMC
Dilokpattanamongkol P, Yan C, Jayanama K, Ngamjanyaporn P, Sungkanuparph S, Rotjanapan P (2024) Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial. BMC Complement Med Ther 24(1):97 PubMed PMC
Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I et al (2023) Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial. Nutrients 15(5):1234 PubMed PMC
Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I et al (2023) Vitamin D supplementation and clinical outcomes in severe COVID-19 patients—randomized controlled trial. Nutrients 15(5):1234 PubMed PMC
Dugald S, Mark L, Ellen C, Caitlyn K, Athanasios P, Tim R et al (2023) Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blind randomised controlled trial. BMJ Open 13(9):e073761 PubMed PMC
Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289(1):F8-28 PubMed
El-Hddad SS, Sobhy MH, El-Morsy A, Shoman NA, El-Adl K (2024) Quinazolines and thiazolidine-2, 4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation. RSC Adv 14(19):13237–13250 PubMed PMC
Erener S (2020) Diabetes, infection risk and COVID-19. Mol Metab 39:101044 PubMed PMC
Farid N, Rola N, Koch EAT, Nakhoul N (2021) Active vitamin D supplementation and COVID-19 infections: review. Irish J Med Sci 190:1–4 PubMed PMC
FDA (2021a) Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. U.S. Food and Drug Administration, December 22, 2021. Available at: https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19. Accessed 1 July 2024
FDA (2021b) Coronavirus (COVID-19) update: FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults. U.S. Food and Drug Administration, December 23, 2021. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizesadditional-oral-antiviral-treatment-covid-19-certain. Accessed 1 July 2024
Fetahu IS, Höbaus J, Kállay E (2014) Vitamin D and the epigenome. Front Physiol 5:164 PubMed PMC
Gallagher JC, Peacock M, Yalamanchili V, Smith LM (2013) Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab 98(3):1137–1146 PubMed PMC
Gambichler T, Bader A, Vojvodic M, Bechara FG, Sauermann K, Altmeyer P et al (2002) Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin. BMC Dermatol 2:6 PubMed PMC
Gorman S, Buckley AG, Ling K-M, Berry LJ, Fear VS, Stick SM et al (2017) Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity. Physiol Rep 5(15):e13371 PubMed PMC
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al (2020) Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4):988 PubMed PMC
Greulich T, Regner W, Branscheidt M, Herr C, Koczulla AR, Vogelmeier CF et al (2017) Altered blood levels of vitamin D, cathelicidin and parathyroid hormone in patients with sepsis—a pilot study. Anaesth Intensive Care 45(1):36–45 PubMed
Griffin G, Hewison M, Hopkin J, Kenny R, Quinton R, Rhodes J et al (2020) Vitamin D and COVID-19: evidence and recommendations for supplementation. R Soc Open Sci 7(12):201912 PubMed PMC
Gutiérrez OM, Farwell WR, Kermah D, Taylor EN (2011) Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the national health and nutrition examination survey. Osteoporos Int 22(6):1745–1753 PubMed PMC
Hardwick LL, Jones MR, Brautbar N, Lee DB (1991) Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr 121(1):13–23 PubMed
Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85(1):6–18 PubMed
Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS et al (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57-73 PubMed
Hodgkinson A, Marshall DH, Nordin BE (1979) Vitamin D and magnesium absorption in man. Clin Sci 57(1):121–123 PubMed
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281 PubMed
Holick MF, Smith E, Pincus S (1987) Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol 123(12):1677–1683 PubMed
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 PubMed
Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88(7):720–755 PubMed PMC
Hribar CA, Cobbold PH, Church FC (2020) Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Sci 10(5):284 PubMed PMC
Huang H, Zheng J, Liu Y, Zhou Q, Peng D (2023) Effect of vitamin D status on adult COVID-19 pneumonia induced by delta variant: a longitudinal, real-world cohort study. Front Med 10:1121256 PubMed PMC
Hussain A, Bhowmik B, do Vale Moreira NC (2020) COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 162:108142 PubMed PMC
Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR et al (2020) Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients 12(6):1562 PubMed PMC
Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium (2011) The National Academies Collection: reports funded by National Institutes of Health. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US) Copyright © 2011, National Academy of Sciences
Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R (2008) Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93(9):3430–3435 PubMed
Ismailova A, White JH (2022) Vitamin D, infections and immunity. Rev Endocr Metab Disord 23(2):265–277 PubMed PMC
Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S (2020) Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 10(1):20191 PubMed PMC
Jäpelt RB, Jakobsen J (2013) Vitamin D in plants: a review of occurrence, analysis, and biosynthesis. Front Plant Sci 4:136 PubMed PMC
Jaun F, Boesing M, Luethi-Corridori G, Abig K, Bloch N, Giezendanner S et al (2023) Effect of single high dose vitamin D substitution in hospitalized COVID-19 patients with vitamin D deficiency on length of hospital stay. Biomedicines 11(5):1277 PubMed PMC
Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88(2):582s-s586 PubMed
Jones G, Prosser DE, Kaufmann M (2012) 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 523(1):9–18 PubMed
Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338(1):40–44 PubMed PMC
Kadambari S, Klenerman P, Pollard AJ (2020) Why the elderly appear to be more severely affected by COVID-19: the potential role of immunosenescence and CMV. Rev Med Virol 30(5):e2144 PubMed PMC
Karahan S, Katkat F (2021) Impact of serum 25 (OH) vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 25(2):189–196 PubMed PMC
Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF (2020) SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15(9):e0239252 PubMed PMC
Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85(8):752–7 PubMed PMC
Khan S, Tombuloglu H, Hassanein SE, Rehman S, Bozkurt A, Cevik E et al (2020) Coronavirus diseases 2019: current biological situation and potential therapeutic perspective. Eur J Pharmacol 886:173447 PubMed PMC
Khazai N, Judd SE, Tangpricha V (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10(2):110–117 PubMed PMC
Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G (2018) Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens 24:9 PubMed PMC
Kow CS, Hadi MA, Hasan SS (2020) Vitamin D supplementation in influenza and COVID-19 infections comment on: “Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths” nutrients 2020, 12 (4), 988. Nutrients 12(6):1626 PubMed PMC
Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A (2021) Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 292:198235 PubMed PMC
Lakkireddy M, Gadiga S, Malathi R, Karra M, Prasad Murthy Raju ISSV (2021) Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 11(1):10641 PubMed PMC
Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD et al (2020) Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv. 10.1101/2020.04.24.20075838 PubMed
LeFevre ML (2015) Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 162(2):133–40 PubMed
MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76(4):1536–1538 PubMed PMC
Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A et al (2021) Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial. Endocr Pract 27(12):1242–1251 PubMed PMC
Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351(9105):805–806 PubMed
Malloy PJ, Peng L, Wang J, Feldman D (2009) Interaction of the vitamin D receptor with a vitamin D response element in the Müllerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 150(4):1580–1587 PubMed PMC
Małyszko J, Tomaszuk-Kazberuk A, Dobrzycki K, Bachórzewska-Gajewska H, Zorawski M, Koc-Zorawska E et al (2019) Vitamin D deficiency and anemia is highly prevalent and dependent on the etiology of heart failure: a pilot study. Cardiol J. 10.5603/CJ.a2019.0003 PubMed PMC
Mamurova B, Akan G, Mogol E, Turgay A, Tuncel G, Evren EU et al (2023) Strong association between vitamin D receptor gene and severe acute respiratory syndrome coronavirus 2 infectious variants. Glob Med Genet 10(01):27–33 PubMed PMC
Manson JE, Brannon PM, Rosen CJ, Taylor CL (2016) Vitamin D deficiency—is there really a pandemic? N Engl J Med 375(19):1817–1820 PubMed
Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G et al (2019) Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess 23(2):1–44 PubMed PMC
Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E (2015) Clinical implications of vitamin D deficiency. Menopause Rev 14(2):75–81 PubMed PMC
Mbata MK, Hunziker M, Makhdoomi A, Lüthi-Corridori G, Boesing M, Giezendanner S et al (2023) Is serum 25-hydroxyvitamin d level associated with severity of COVID-19? A retrospective study. J Clin Med 12(17):5520 PubMed PMC
Meckel K, Li YC, Lim J, Kocherginsky M, Weber C, Almoghrabi A et al (2016) Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis. Am J Clin Nutr 104(1):113–120 PubMed PMC
Meftahi GH, Jangravi Z, Sahraei H, Bahari Z (2020) The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging.” Inflamm Res 69(9):825–839 PubMed PMC
Mercola J, Grant WB, Wagner CL (2020) Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients 12(11):3361 PubMed PMC
Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I et al (2020) Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 287(17):3693–3702 PubMed PMC
Meyerowitz EA, Scott J, Richterman A, Male V, Cevik M (2024) Clinical course and management of COVID-19 in the era of widespread population immunity. Nat Rev Microbiol 22(2):75–88 PubMed
Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A et al (2012) Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann Nutr Metab 61(4):337–348 PubMed
Miroliaee AE, Salamzadeh J, Shokouhi S, Sahraei Z (2018) The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care 44:300–305 PubMed
Mizwicki MT, Norman AW (2009) The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal 2(75):re4 PubMed
Mohan M, Cherian JJ, Sharma A (2020) Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog 16(9):e1008874 PubMed PMC
Molnár F, Peräkylä M, Carlberg C (2006) Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J Biol Chem 281(15):10516–10526 PubMed
Molnár F, Sigüeiro R, Sato Y, Araujo C, Schuster I, Antony P et al (2011) 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS ONE 6(3):e18124 PubMed PMC
Mulligan GB, Licata A (2010) Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res 25(4):928–930 PubMed
Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CS et al (2020) Effect of vitamin D3 supplementation vs placebo on hospital length of stay in patients with severe COVID-19: a multicenter, double-blind, randomized controlled trial. Medrxiv. 10.1101/2020.11.16.20232397
Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26(5):662–687 PubMed
Nehme J, Borghesan M, Mackedenski S, Bird TG, Demaria M (2020) Cellular senescence as a potential mediator of COVID-19 severity in the elderly. Aging Cell 19(10):e13237 PubMed PMC
Niraj N, Mahajan SS, Prakash A, Sarma P, Medhi B (2022) Paxlovid: a promising drug for the challenging treatment of SARS-COV-2 in the pandemic era. Indian J Pharmacol 54(6):452–458 PubMed PMC
Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147(12):5542–5548 PubMed
Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88(2):491s-s499 PubMed
Ong LTC, Booth DR, Parnell GP (2020) Vitamin D and its effects on DNA methylation in development, aging, and disease. Mol Nutr Food Res. 64:e2000437 PubMed
Orchard L, Baldry M, Nasim-Mohi M, Monck C, Saeed K, Grocott MPW et al (2021) Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med. 10.1515/cclm-2020-1567 PubMed
Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S et al (2021) An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science 374(6575):1586–1593 PubMed
Pal R, Bhadada SK (2020) COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr 14(4):513–517 PubMed PMC
Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D et al (2020) Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol 93(4):508–511 PubMed PMC
Peng D, Huang H, Liu Z, Gao Y, Liu Y (2022) Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: a longitudinal cohort study. Front Nutr 9:960859 PubMed PMC
Pereira M, Dantas Damascena A, Galvão Azevedo LM, de Almeida Oliveira T, da Mota Santana J (2020) Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr 62:1–9 PubMed
Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V et al (2020) COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 32(8):1599–1608 PubMed PMC
Pike JW, Meyer MB (2010) The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 39(2):255–69 PubMed PMC
Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5(7):2502–2521 PubMed PMC
Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N et al (2022) Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J 98(1156):87–90 PubMed
Rehman S, Majeed T, Azam Ansari M, Ali U, Sabit H, Al-Suhaimi EA (2020) Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi J Biol Sci 27(10):2567–2573 PubMed PMC
Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA (2021a) Perspective: vitamin D deficiency and COVID-19 severity—plausibly linked by latitude, ethnicity, impacts on cytokines, ACE 2 and thrombosis. J Intern Med 289(1):97–115 PubMed PMC
Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA (2021b) Perspective: vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern Med 289(1):97–115 PubMed PMC
Richard A, Rohrmann S, Quack Lötscher KC (2017) Prevalence of vitamin D deficiency and its associations with skin color in pregnant women in the first trimester in a sample from Switzerland. Nutrients 9(3):260 PubMed PMC
Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA et al (2012) IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97(4):1146–1152 PubMed PMC
Sabico S, Enani MA, Sheshah E, Aljohani NJ, Aldisi DA, Alotaibi NH et al (2021) Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial. Nutrients 13(7):2170 PubMed PMC
Sarhan N, Abou Warda AE, Sarhan RM, Boshra MS, Mostafa-Hedeab G, ALruwaili BF et al (2022) Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial. Medicina 58(10):1358 PubMed PMC
Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R et al (2020) COVID-19 and older adults: what we know. J Am Geriatr Soc 68(5):926–929 PubMed PMC
Sidiropoulou P, Docea AO, Nikolaou V, Katsarou MS, Spandidos DA, Tsatsakis A et al (2021) Unraveling the roles of vitamin D status and melanin during Covid-19 (review). Int J Mol Med 47(1):92–100 PubMed PMC
Singh SK, Jain R, Singh S (2020a) Vitamin D deficiency in patients with diabetes and COVID-19 infection. Diabetes Metab Syndr 14(5):1033–1035 PubMed PMC
Singh AK, Gupta R, Ghosh A, Misra A (2020b) Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 14(4):303–310 PubMed PMC
Snegarova V, Naydenova D (2020) Vitamin D: a review of its effects on epigenetics and gene regulation. Folia Med 62(4):662–667 PubMed
Speeckaert MM, Delanghe JR (2020) Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein. Aging Clin Exp Res 32(7):1207–1208 PubMed PMC
Sung CC, Liao MT, Lu KC, Wu CC (2012) Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012:634195 PubMed PMC
Sutton AL, MacDonald PN (2003) Vitamin D: more than a “bone-a-fide” hormone. Mol Endocrinol 17(5):777–791 PubMed
Szymczak-Pajor I, Drzewoski J, Śliwińska A (2020) The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci 21(18):6644 PubMed PMC
Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY et al (2020) A cohort study to evaluate the effect of combination vitamin D, magnesium and vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients. MedRxiv. 10.1016/j.nut.2020.111017 PubMed PMC
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657–666 PubMed
Tony MA, Nabwey HA (2024) Recent advances in solar still technology for solar water desalination. Appl Water Sci 14(7):147
Valdivielso JM (2009) The physiology of vitamin D receptor activation. Contrib Nephrol 163:206–212 PubMed
van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97(1–2):93–101 PubMed
Vassiliou AG, Jahaj E, Pratikaki M, Orfanos SE, Dimopoulou I, Kotanidou A (2020) Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU cohort. Nutrients 12(12):3773 PubMed PMC
Veldurthy V, Wei R, Oz L, Dhawan P, Jeon YH, Christakos S (2016) Vitamin D, calcium homeostasis and aging. Bone Res 4:16041 PubMed PMC
Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69(5):842–856 PubMed
Wang T, Liu Z, Fu J, Min Z (2019) Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure. Scand Cardiovasc J 53(3):110–116 PubMed
Wasserman RH (2004) Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 134(11):3137–3139 PubMed
Watts KM, Lahiri P, Arrazuria R, De Buck J, Knight CG, Orsel K et al (2020) Oxytetracycline reduces inflammation and treponeme burden whereas vitamin D 3 promotes β-defensin expression in bovine infectious digital dermatitis. Cell Tissue Res 379(2):337 PubMed
Webb AR (2006) Who, what, where and when—influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92(1):17–25 PubMed
Weir EK, Thenappan T, Bhargava M, Chen Y (2020) Does vitamin D deficiency increase the severity of COVID-19? Clin Med 20(4):e107–e108 PubMed PMC
Welch AA, Skinner J, Hickson M (2017) Dietary magnesium may be protective for aging of bone and skeletal muscle in middle and younger older age men and women: cross-sectional findings from the UK Biobank cohort. Nutrients 9(11):1189 PubMed PMC
Wimalawansa SJ, Vitamin D (2019) Deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology 8(2):30 PubMed PMC
Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H (2017) Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16(5):7432–7438 PubMed PMC
Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G et al (2021) Does serum vitamin D level affect COVID-19 infection and its severity?—A case-control study. J Am Coll Nutr 40(8):724–731 PubMed
Yisak H, Ewunetei A, Kefale B, Mamuye M, Teshome F, Ambaw B et al (2021) Effects of vitamin D on COVID-19 infection and prognosis: a systematic review. Risk Manag Healthc Policy 14:31–38 PubMed PMC
Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188(5):2127–2135 PubMed PMC
Zhou R, Chun RF, Lisse TS, Garcia AJ, Xu J, Adams JS et al (2015) Vitamin D and alternative splicing of RNA. J Steroid Biochem Mol Biol 148:310–317 PubMed PMC
Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF (2013) CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci U S A 110(39):15650–15655 PubMed PMC
Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11(1):25–33 PubMed